A randomized phase III study comparing etoposide and cisplatin with etoposide, cisplatin and paclitaxel in patients with extensive small cell lung cancer.
Phase of Trial: Phase III
Latest Information Update: 21 Jul 2016
At a glance
- Drugs Paclitaxel (Primary) ; Cisplatin; Etoposide; Filgrastim
- Indications Small cell lung cancer
- Focus Registrational; Therapeutic Use
- 27 Sep 2013 Additional lead trial centre added as reported by ClinicalTrials.gov.
- 02 Mar 2011 Actual end date (Jan 2006) added as reported by ClinicalTrials.gov.
- 02 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.